Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001
-
Shares outstanding
-
62,162,717
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
50,329,296
-
Shares change
-
+1,155,656
-
Total reported value, excl. options
-
$1,191,811,689
-
Value change
-
-$6,168,618
-
Put/Call ratio
-
37%
-
Number of buys
-
70
-
Number of sells
-
72
-
Price
-
$23.68
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) as of Q1 2022
As of 31 Mar 2022 Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) had 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,329,296 shares of stock of the company.
Largest 10 holders included FMR LLC, RTW INVESTMENTS, LP, BVF INC/IL, STATE STREET CORP, BlackRock Inc., Point72 Asset Management, L.P., JOHNSON & JOHNSON, VANGUARD GROUP INC, MORGAN STANLEY, and FARALLON CAPITAL MANAGEMENT LLC.
This table shows 136 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.